Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001096906-21-000293

← back to feed
Filed
Feb 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Feb 9, 2021 203.3M sh
Short Term Debt Q2 2021 · Dec 31, 2020 $739.55K
Short Term Debt Q2 2021 · Jun 30, 2020 $618.57K
Stockholders Equity Q2 2021 · Dec 31, 2020 −$232.84K
Stockholders Equity Q2 2021 · Jun 30, 2020 −$82.9K
Current Liabilities Q2 2021 · Dec 31, 2020 $940.44K
Current Liabilities Q2 2021 · Jun 30, 2020 $791.49K
Total Liabilities Q2 2021 · Dec 31, 2020 $1M
Total Liabilities Q2 2021 · Jun 30, 2020 $855.21K
Current Assets Q2 2021 · Dec 31, 2020 $40.63K
Current Assets Q2 2021 · Jun 30, 2020 $48.7K
Total Assets Q2 2021 · Dec 31, 2020 $121.17K
Total Assets Q2 2021 · Jun 30, 2020 $125.33K
Operating Cash Flow Q2 2021 · Dec 31, 2019 −$78.88K
Cash And Equivalents Q2 2021 · Dec 31, 2019 $15.4K
Cash And Equivalents Q2 2021 · Jun 30, 2019 $27.45K
Sga Expense Q2 2021 · Dec 31, 2019 $7.9K
Sga Expense Q2 2021 · Dec 31, 2019 $20.09K
Rd Expense Q2 2021 · Dec 31, 2019 $2.65K
Rd Expense Q2 2021 · Dec 31, 2019 $4.89K
Net Income Q2 2021 · Dec 31, 2019 −$53.98K
Net Income Q2 2021 · Dec 31, 2019 −$96.73K
Operating Income Q2 2021 · Dec 31, 2019 −$36.53K
Operating Income Q2 2021 · Dec 31, 2019 −$92.43K
Gross Profit Q2 2021 · Dec 31, 2019 $11.68K
Gross Profit Q2 2021 · Dec 31, 2019 $11.97K
Revenue Q2 2021 · Dec 31, 2019 $11.68K
Revenue Q2 2021 · Dec 31, 2019 $11.97K